April 10, 2022


🚨 Investment Opportunity🚨

As a Daily Dropout reader, you are invited to invest in this week's startup, NowRx

Invest in NowRx

Staffing issues, long lines, outdated tech - retail pharmacy could use a serious revamp. This week’s startup is giving the $480B industry the prescription it needs.

⚾ The Elevator Pitch

Think US health care, and the word “broken” comes to mind. Inconvenient, expensive, and overall just an unpleasant experience - especially in the pharmacy where filling prescriptions can sometimes feel like getting teeth pulled.

NowRx solves this by leveraging proprietary technology to provide pharmacy the way it should be - reliable, affordable, and convenient. The company’s award-winning “QuickFill” system automates prescription processing and dispensing in under 30 seconds – all while dramatically reducing costs and common pharmacy errors.

Best of all, unlike mail pharmacies, NowRx is local and uses its own HIPAA-certified employees to deliver medications which means no unexpected delays at the post office.

All of that equals a fast, convenient, hassle-free experience for customers.

The AlleyWatch Startup Daily Funding Report: 12/14/2021 - AlleyWatch

👇 The Drop Down

Site: https://nowrx.com/
Founded: 2015
Stage: Actively Raising  Series C - Invest Today
Tech trend: On-Demand Healthcare & Robotics
Traction: $26M in annualized revenue, 81% CAGR since 2016, 8 locations with 3 more announced for 2022, 2021 Surescripts White Coat Award Winner, $20M Series B sold out on SeedInvest, $13.5M already raised from 4,200 in Series C, featured in major publications like CNET, Entrepreneur, Benzinga, and CNBC.

Team - Successful Entrepreneurs, Investors, and Medical Professionals
Cary Breese (CEO) | Summet Sheokand (CTO) | Melissa Bostock (DOP)

🔍 Why we like it

  1. 🤖 Bringing Modern Technology to an Antiquated Industry
    NowRx’s award winning QuickFill system replaces manual processes and inefficient operations inside the pharmacy, which means less errors, better service, and ultimately a better overall customer experience. In addition, a single NowRx can service the same geographic area as 20 CVS and Walgreens for a fraction of the cost providing significant cost savings.
  2. 🚀 Massive TAM and Proven Growth
    The retail pharmacy industry is worth a staggering $480B and with over $26M in annualized revenue as of December, NowRx is proving itself in a market that offers plenty of room for additional growth! With 8 locations and several more already announced for 2022, you have to like the company’s potential. Furthermore, NowRx recently entered the $61B+ telehealth market with their new Telehealth offering which grew over 1,200% from Q1 to Q4 providing an additional revenue stream in another enormous market.
  1. 🔥 Raving Customers
    Perhaps the most impressive thing about NowRx is the pack of raving fans the company has developed. The tech-powered pharmacy holds an incredible 5.0 rating on Yelp at every single location and a 91 NPS from physician staff that have used the service with 97% saying they are “extremely” or “very likely” to use NowRx again. Add in 14,000+ investors and NowRx already has traction in every new city they launch.

🚀 You’ve read about them, but are you ready to invest?

NowRx is raising a Series C round that you can join in on. They will be using funds to further fuel their growth and launch new pharmacy territories nationwide. Learn more about NowRx here.

Take me to invest

🤝 Get Involved